Hyperinsulineamia as Risk Factor for Early Breast Cancer Recurrence Linked to Hormone Receptors and Human Epidermal Growth Factor Receptor 2
Journal Title: Journal of Diabetes and Obesity - Year 2017, Vol 4, Issue 3
Abstract
Background: Hyperinsuliunemia is a condition with excess levels of circulating insulin in the blood among non-diabetics. Hyperinsuliunemia may increase breast cancer developing probability. Purpose: to investigate the role of hyperinsuliunemia in early recurrence in breast cancer by estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2). Methods: 50 patients with invasive breast cancer in stage II and III in age range 17 - 65 years, involved in this study and classified into five subtypes of ER, PR and HER2, and followed prospectively for 2 years from beginning treatment based on insulin serum levels. Results: In newly diagnosed patients the mean concentrations and standard deviation were (17.11 ± 10.17), while the insulin levels in the patients after chemotherapy treatment were (26.06 ± 15.69), when the tow means were compared by t. test the blood concentration of insulin was high significantly in patients as control (p > 0.001). Regarding hormone receptors and HER2, the insulin levels in ER−PR−HER2− and ER− PR−HER2+ increased significantly after chemotherapy (p = 0.005 and 0.047) respectively. 10 of triple negative breast cancer patients suffered recurrence. Conclusion: Hyperinsuliunemia and weight change after chemotherapy may consider as risk factors for breast cancer recurrence among patients with triple-negative breast cancer.
Authors and Affiliations
Alkhansa Salih Mahmoud
Keywords
Related Articles
- EP ID EP418208
- DOI 10.15436/2376-0494.17.1323
- Views 105
- Downloads 0
OBESITY-RELATED HORMONES AND METABOLIC RISK FACTORS: A RANDOMIZED TRIAL OF DIET PLUS EITHER STRENGTH OR AEROBIC TRAINING VERSUS DIET ALONE IN OVERWEIGHT PARTICIPANTS
There is debate about the additive effects of exercise in conjunction with diet to treat obesity, and not much is known about the differential effects of strength versus aerobic training. This randomized controlled trial...
Vagal Nerve Block for Improvements in Glycemic Control in Obese Patients with Type 2 Diabetes Mellitus: Three-Year Results of the VBLOC DM2 Study
Background: The VBLOC DM2 study demonstrated that intermittent electrical vagal blocking (vBloc therapy) was safe among subjects with obesity and type 2 diabetes mellitus (DM2) and led to clinically meaningful improvemen...
Effect of Haematogenous oxidation therapy with Ultraviolet-C irridation in an alloxan-induced diabetes and a Poloxamer 407-induced Hyperlipidemia in rabbits
Background Recently diabetes and hyperlipidemia HL considered a major source of mortality Chemical treatments could minimize the symptoms but still the disease exists Previously Ultraviolet was usedfor treatment...
Amelioration of Diabetic Dyslipidemia by GTF – 231 (Gymnemic acid, Trigonelline and Ferulic acid- 2:3:1), a phytochemical preparation Studied in High Fat Diet Fed-Low Dose STZ Induced Experimental Type 2 Diabetes in Rats
Background Persistent hyperglycemia in diabetes is associated with profound changes in lipid and lipoprotein abnormalities which result in particle distribution within lipoprotein classes Recently we have reported...
Fructose Intake and Circulating Triglycerides: An Examination of the Role of APOC 3
Fructose consumption can lead to marked increases in plasma triglycerides in both humans and laboratory animals. We have observed that overnight access to a 16% fructose solution can promote hypertriglyceridemia in rats....